Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Explainer
  • Published:

Should experimental drugs be used in the Ebola outbreak?

This article has been updated

Nature examines the risks and benefits of unproven Ebola treatments, as World Health Organization says it is ethical to use them in West African crisis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 12 August 2014

    This story contains additions since it was first posted to incorporate reporting from a subsequent World Health Organization press conference.

Authors

Additional information

Follow Erika Check Hayden on Twitter @Erika_Check.

Related links

Related links

Related links in Nature Research

Ebola declared a public-health emergency 2014-Aug-08

Largest ever Ebola outbreak is not a global threat 2014-Jul-30

Ebola treatments caught in limbo 2014-Jul-29

Barriers to trust 2014-Jul-09

Nature special: Ebola outbreak in West Africa

Related external links

Information on Ebola from the US Centers for Disease Control and Prevention

Information on the Ebola outbreak from the World Health Organization

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Check Hayden, E., Reardon, S. Should experimental drugs be used in the Ebola outbreak?. Nature (2014). https://doi.org/10.1038/nature.2014.15698

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2014.15698

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing